活动性银屑病关节炎-话题@MedSci

#活动性银屑病关节炎#

14篇内容 | 858人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1491006, encodeId=d8e714910062c, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=A&R：比美吉珠单抗治疗活动性银屑病关节炎的安全性和有效性研究, objectType=article, longId=732834, objectId=ef20e328345b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef20e328345b, replyNumber=0, likeNumber=51, createdTime=2022-07-21, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef20e328345b, moduleTitle=A&R：比美吉珠单抗治疗活动性银屑病关节炎的安全性和有效性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef20e328345b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491005, encodeId=925c149100544, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Ann Rheum Dis：瑞莎珠单抗治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1试验24周结果, objectType=article, longId=725974, objectId=3d38e2597445, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d38e2597445, replyNumber=0, likeNumber=39, createdTime=2022-05-03, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d38e2597445, moduleTitle=Ann Rheum Dis：瑞莎珠单抗治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1试验24周结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d38e2597445)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491004, encodeId=0b311491004d0, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Arthritis Rheumatol：利桑珠单抗治疗活动性银屑病关节炎的疗效和安全性：3期KEEPsAKE 2试验的24周结果, objectType=article, longId=301767, objectId=e074301e677e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e074301e677e, replyNumber=0, likeNumber=46, createdTime=2022-03-28, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e074301e677e, moduleTitle=Arthritis Rheumatol：利桑珠单抗治疗活动性银屑病关节炎的疗效和安全性：3期KEEPsAKE 2试验的24周结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e074301e677e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491003, encodeId=230f149100339, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Rheumatology：Apremilast单药治疗DMARD无效的活动性银屑病关节炎的长期疗效, objectType=article, longId=301742, objectId=ea63301e42f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea63301e42f2, replyNumber=0, likeNumber=40, createdTime=2022-03-28, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea63301e42f2, moduleTitle=Rheumatology：Apremilast单药治疗DMARD无效的活动性银屑病关节炎的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea63301e42f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491002, encodeId=fb3914910026c, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Ann Rheum Dis：瑞莎珠单抗治疗对活动性银屑病关节炎的疗效和安全性分析, objectType=article, longId=221074, objectId=c0212210e40d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0212210e40d, replyNumber=0, likeNumber=59, createdTime=2021-11-27, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0212210e40d, moduleTitle=Ann Rheum Dis：瑞莎珠单抗治疗对活动性银屑病关节炎的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0212210e40d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491001, encodeId=181e149100195, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Lancet Rheumatology：Guselkumab对活动性银屑病关节炎和骶髂关节炎患者中轴受累的疗效, objectType=article, longId=219178, objectId=43202191e830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43202191e830, replyNumber=0, likeNumber=42, createdTime=2021-10-26, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43202191e830, moduleTitle=Lancet Rheumatology：Guselkumab对活动性银屑病关节炎和骶髂关节炎患者中轴受累的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43202191e830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491000, encodeId=ecd0149100061, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Ann Rheum Dis：替拉珠单抗治疗活动性银屑病关节炎的疗效和安全性——随机、双盲、安慰剂对照、多剂量、52周的IIb期研究结果, objectType=article, longId=218828, objectId=bead21882881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bead21882881, replyNumber=0, likeNumber=44, createdTime=2021-10-20, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bead21882881, moduleTitle=Ann Rheum Dis：替拉珠单抗治疗活动性银屑病关节炎的疗效和安全性——随机、双盲、安慰剂对照、多剂量、52周的IIb期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bead21882881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490999, encodeId=ac93149099907, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=欧盟委员会批准了TREMFYA®（guselkumab）治疗活动性银屑病关节炎（PsA）, objectType=article, longId=203779, objectId=0bb5203e7985, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bb5203e7985, replyNumber=0, likeNumber=49, createdTime=2020-11-28, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bb5203e7985, moduleTitle=欧盟委员会批准了TREMFYA®（guselkumab）治疗活动性银屑病关节炎（PsA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bb5203e7985)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490998, encodeId=d2bb1490998d8, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=TREMFYA（guselkumab）治疗活动性银屑病关节炎（PsA）：已获得CHMP的积极意见, objectType=article, longId=202280, objectId=18ae2022800c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18ae2022800c, replyNumber=0, likeNumber=49, createdTime=2020-10-21, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18ae2022800c, moduleTitle=TREMFYA（guselkumab）治疗活动性银屑病关节炎（PsA）：已获得CHMP的积极意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18ae2022800c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490997, encodeId=a146149099e8e, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Lancet：白细胞介素23单抗Guselkumab治疗活动性银屑病关节炎, objectType=article, longId=191455, objectId=80f2191455c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80f2191455c6, replyNumber=0, likeNumber=40, createdTime=2020-04-06, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80f2191455c6, moduleTitle=Lancet：白细胞介素23单抗Guselkumab治疗活动性银屑病关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80f2191455c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490996, encodeId=15731490996b1, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=FDA批准Cosentyx治疗关节活动性银屑病关节炎（PsA）, objectType=article, longId=141713, objectId=7d96141e13fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d96141e13fa, replyNumber=0, likeNumber=54, createdTime=2018-06-28, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d96141e13fa, moduleTitle=FDA批准Cosentyx治疗关节活动性银屑病关节炎（PsA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d96141e13fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490995, encodeId=b9e414909950d, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Ann Rheum Dis：苏金单抗改善活动性银屑病关节炎的症状并抑制影像学进展, objectType=article, longId=132812, objectId=122f1328125d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=122f1328125d, replyNumber=0, likeNumber=50, createdTime=2018-03-20, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=122f1328125d, moduleTitle=Ann Rheum Dis：苏金单抗改善活动性银屑病关节炎的症状并抑制影像学进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=122f1328125d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490994, encodeId=6c2b14909944f, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Arthritis Rheumatol：活动性银屑病关节炎静脉注射戈利木单抗的安全性和有效性, objectType=article, longId=108861, objectId=02791088610f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02791088610f, replyNumber=0, likeNumber=42, createdTime=2017-08-17, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02791088610f, moduleTitle=Arthritis Rheumatol：活动性银屑病关节炎静脉注射戈利木单抗的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02791088610f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490993, encodeId=b5b2149099336, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=2015NICE技术评估指南——阿普斯特治疗活动性银屑病关节炎（TA372）发布, objectType=article, longId=79983, objectId=a20ce9983ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a20ce9983ea, replyNumber=0, likeNumber=43, createdTime=2016-10-14, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a20ce9983ea, moduleTitle=2015NICE技术评估指南——阿普斯特治疗活动性银屑病关节炎（TA372）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a20ce9983ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

活动性银屑病关节炎

2020-05-29

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

A&R：比美吉珠单抗治疗活动性银屑病关节炎的安全性和有效性研究

2022-07-21

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Ann Rheum Dis：瑞莎珠单抗治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1试验24周结果

2022-05-03

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Arthritis Rheumatol：利桑珠单抗治疗活动性银屑病关节炎的疗效和安全性：3期KEEPsAKE 2试验的24周结果

2022-03-28

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Rheumatology：Apremilast单药治疗DMARD无效的活动性银屑病关节炎的长期疗效

2022-03-28

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Ann Rheum Dis：瑞莎珠单抗治疗对活动性银屑病关节炎的疗效和安全性分析

2021-11-27

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Lancet Rheumatology：Guselkumab对活动性银屑病关节炎和骶髂关节炎患者中轴受累的疗效

2021-10-26

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Ann Rheum Dis：替拉珠单抗治疗活动性银屑病关节炎的疗效和安全性——随机、双盲、安慰剂对照、多剂量、52周的IIb期研究结果

2021-10-20

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

欧盟委员会批准了TREMFYA®（guselkumab）治疗活动性银屑病关节炎（PsA）

2020-11-28

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

TREMFYA（guselkumab）治疗活动性银屑病关节炎（PsA）：已获得CHMP的积极意见

2020-10-21

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Lancet：白细胞介素23单抗Guselkumab治疗活动性银屑病关节炎

2020-04-06

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

FDA批准Cosentyx治疗关节活动性银屑病关节炎（PsA）

2018-06-28

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Ann Rheum Dis：苏金单抗改善活动性银屑病关节炎的症状并抑制影像学进展

2018-03-20

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Arthritis Rheumatol：活动性银屑病关节炎静脉注射戈利木单抗的安全性和有效性

2017-08-17

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

2015NICE技术评估指南——阿普斯特治疗活动性银屑病关节炎（TA372）发布

2016-10-14

科室
- - 订阅+
  - 更多科室
工具
服务